(Q41130252)

English

Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis

scientific article published on 30 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis (English)

1 reference

Europe PubMed Central

27 September 2017

0 references

Ruta Petraitiene

1

object named as

Ruta Petraitiene

1 reference

Europe PubMed Central

27 September 2017

Vidmantas Petraitis

2

object named as

Vidmantas Petraitis

1 reference

Europe PubMed Central

27 September 2017

5

object named as

Thomas J Walsh

1 reference

Europe PubMed Central

27 September 2017

3

object named as

John D Bacher

1 reference

Europe PubMed Central

27 September 2017

Malcolm A Finkelman

4

object named as

Malcolm A Finkelman

1 reference

Europe PubMed Central

27 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 June 2015

1 reference

Europe PubMed Central

27 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Medical Mycology

1 reference

Europe PubMed Central

27 September 2017

53

1 reference

Europe PubMed Central

27 September 2017

6

1 reference

Europe PubMed Central

27 September 2017

558-568

1 reference

Europe PubMed Central

27 September 2017

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Laboratory diagnosis of invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Advances in diagnostic testing

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Invasive aspergillosis in glucocorticoid-treated patients.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Calcineurin-mediated regulation of hyphal growth, septation, and virulence in Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYV034

21 January 2018

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

10.1093/MMY/MYV034

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41130252&oldid=2094120884"